GH Research (GHRS) Capital Expenditures (QoQ) (2021 - 2025)
GH Research (GHRS) Capital Expenditures (QoQ) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
GH Research |
9.73 Bn |
9.63 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
51.28% |
| Sep 30, 2025 |
33.90% |
| Jun 30, 2025 |
-1,375.00% |
| Mar 31, 2025 |
84.00% |
| Dec 31, 2024 |
-525.00% |
| Sep 30, 2024 |
50.00% |
| Jun 30, 2024 |
33.33% |
| Mar 31, 2024 |
-106.82% |
| Dec 31, 2023 |
2,300.00% |
| Sep 30, 2023 |
82.61% |
| Jun 30, 2023 |
-109.09% |
| Mar 31, 2023 |
-118.97% |
| Dec 31, 2022 |
873.33% |
| Sep 30, 2022 |
37.50% |
| Jun 30, 2022 |
-140.00% |
| Mar 31, 2022 |
-105.29% |
| Dec 31, 2021 |
478.00% |
| Sep 30, 2021 |
-257.14% |
| Jun 30, 2021 |
33.33% |
